MDRI adds two new clinical trials for Psoriasis
The Menter Dermatology Research Institute is seeking participants for two new psoriasis clinical trials as well as participants for many ongoing studies. Please contact us if you need more information on any of our clinical research studies. For further information on all of our clinical trials, visit our Clinical Trials page.
Moderate to severe psoriasis
Ages: 18 and older
Both male and female participants welcome
New clinical trial additions:
- Janssen 7244 – A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
- Janssen 3032 – A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab